Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Marek Malecki


Marek Malecki

Phoenix Biomolecular Engineering Foundation, USA

Biography

Marek Malecki MD PhD is President of the Phoenix Foundation, Visiting Professor at the University of Wisconsin, Principal Investigator for the National Institutes of Health. He earned the MD degree at the Medical Academy, Poznan followed by Residency/Fellowships in Molecular Medicine in Rigshospitalet, Copenhagen, Cancer Center, Vienna, Cancer Center, Amsterdam, NL, and Cancer Center, Warsaw. He earned the PhD degree at the Polish Academy of Sciences, Warsaw followed by the postdoctoral fellowships in molecular biology at the Austrian Academy of Sciences, Salzburg, ETH, Zurich, Utrecht University, Utrecht, Cancer Center, Amsterdam, Biozentrum, Basel. Over the last 20 years, he held faculty positions in Oncology, Molecular Medicine, and Pharmacology, at the top teaching hospitals and medical universities in the USA. There, he acquired solid experience in streamlining advances in genomics and proteomics into novel strategies of therapy, as well as in teaching medical students, residents, and fellows. He was elected by his students and fellow faculty to the Honor Society for Excellence in Teaching and as a Faculty Role Model. His research, as the Principal Investigator, was continuously funded by the grants from the National Science Foundation and the National Institutes of Health since 1989. He is the first or senior author on the peer-reviewed publications in the high impact journals, which are indexed on the PubMed and justified  hisrecommendation to the Faculty of 1000 Prime. He is the inventor of the gene therapies, therapeutic vaccines, and regeneration of tissues, which are published at the USPTO and WIPO with the sequences available through the NCBI. He was elected to serve as the Editor in Chief in peer-reviewed, open-access journals in Science, Technology, and Medicine, as well as Editorial Board Member and Reviewer at many others.

Abstract

Abstract : Universal therapeutic vaccine against influenza